Tales from a Survivor: An Interview with Author Paul Kraus


By Natasha Lewin

Paul Kraus, author of “Surviving Mesothelioma.”

Paul Kraus, author of
“Surviving Mesothelioma.”

Author Paul Kraus has not only fought cancer, he’s also the only (documented) person to have been born in a Nazi labor camp and escaped. As the longest living mesothelioma survivor in the world, Paul describes himself as an “optimist.”

The Kraus family immigrated to Australia after WWII where Paul worked in a factory cutting asbestos sheets throughout his college years. He was diagnosed with mesothelioma — the asbestos-caused cancer — at age 52. After being told surgery and chemotherapy would offer little help, Kraus created his own treatment plan with non-conventional physicians. While the usual survival rate for someone with mesothelioma is only one year, Paul will now surpass his 16th year fighting the disease.

When asked what prompted him to write his most recent book Surviving Mesothelioma and Other Cancers, Paul responds, “Suffering from a cancer with such a poor prognosis and given the fact that I had outlived my prognosis ten-fold in 2005, I felt that my fellow sufferers needed the inspiration that came from reading my story.”

Paul’s experiences fighting for his life have made him more in tune with the world around him. His gratitude and appreciation have also helped him hone his craft as a writer. “My struggles with cancer and heart problems have changed me as an author. My subsequent cancers, prostate and a benign brain tumor were all pointers to the fact that our time is finite and we need to use it carefully. My illnesses have shown me that our time is a gift that we need to nurture.”

Surviving Mesothelioma is the best-selling book on the subject. Cancer expert Dr. Bernie Siegel said, “Paul Kraus’ book has all the information a cancer patient needs to have in order to learn what survival behavior is about.”

To learn more, go to: survivingmesothelioma.com.

Views All Time
Views All Time
Views Today
Views Today

About Author

Comments are closed.